Shen Ling Bai Zhu San

Shen Ling Bai Zhu San (参苓白术散, Shēn Líng Bái Zhú Sǎn) is a classical Chinese herbal formula first recorded in the Tai Ping Hui Min He Ji Ju Fang (太平惠民和剂局方, Prescriptions of the Taiping Welfare Dispensary) during the Song Dynasty (c. 1107 CE). The formula name identifies its principal herbs: Shen (参) refers to Ren Shen (ginseng), Ling (苓) refers to Fu Ling (Poria), and Bai Zhu (白术) refers to Bai Zhu (Atractylodes macrocephala) — together forming the core Qi-tonifying and dampness-draining triad. San (散) denotes the powder formulation format, indicating the herbs were originally ground into a fine powder.

In the TCM classification system, Shen Ling Bai Zhu San belongs to the category of Qi-tonifying formulas (bu qi ji, 补气剂) within the broader group of tonifying formulas (bu yi ji, 补益剂). Its therapeutic strategy encompasses three interconnected actions: tonifying Spleen Qi (bu pi qi, 补脾气), draining Dampness (li shi, 利湿), and stopping diarrhea (zhi xie, 止泻). This triple action targets the classic pathological presentation of Spleen deficiency with Dampness — a pattern characterized by poor appetite, chronic loose stools, fatigue, and a sallow complexion.

Within TCM education, Shen Ling Bai Zhu San is considered a paradigmatic formula for understanding the classical principle of “tonifying Qi while simultaneously resolving Dampness” (bu qi li shi, 补气利湿). Unlike simple tonifying formulas that may aggravate Dampness by nourishing without draining, Shen Ling Bai Zhu San achieves a sophisticated balance — strengthening the Spleen's transformative capacity while actively removing accumulated fluids. The inclusion of Jie Geng (Platycodon) as the envoy herb reflects an additional layer of sophistication: by opening the Lung pathway, it supports the Spleen's upward-transforming function, reinforcing the classical principle that “the earth element generates the metal element” (tu sheng jin, 土生金).

In modern TCM clinical practice, Shen Ling Bai Zhu San is one of the most frequently prescribed formulas, often in its granule form (Shen Ling Bai Zhu Granules, 参苓白术颗粒). It is discussed in the context of chronic gastrointestinal conditions — including chronic diarrhea, diarrhea-predominant irritable bowel syndrome (IBS-D), and chronic gastritis — as well as respiratory conditions involving Spleen-Lung Qi deficiency such as chronic bronchitis and chronic cough with sputum production. It is also referenced for pediatric applications including childhood malnutrition (xiao ji zhi ji, 小儿疳积) and chronic childhood diarrhea. It is worth noting that these correspondences between TCM patterns and modern biomedical conditions are conceptual analogies, not equivalences. Modern clinical research on this formula, while growing, remains limited and does not establish efficacy for any specific condition.

The Tai Ping Hui Min He Ji Ju Fang (太平惠民和剂局方, Prescriptions of the Taiping Welfare Dispensary) is one of the most significant formularies in Chinese medical history. Commissioned by the Song Dynasty imperial government, this work was compiled by the Bureau of Reimbursement and Welfare Pharmacies (He Ji Ju, 和剂局) and represents one of the earliest systematic efforts to standardize and mass-produce herbal formulations for public welfare. The final edition, published around 1107 CE during the reign of Emperor Huizong, contains over 700 formulas and represents the culmination of several centuries of clinical experience from the imperial medical establishment.

Shen Ling Bai Zhu San was designed within this institutional context as a formula for strengthening the Spleen and resolving Dampness-related digestive disorders. The formula reflects the Song Dynasty medical emphasis on harmonizing the Spleen and Stomach — a therapeutic focus that distinguished Song medicine from earlier Han Dynasty approaches centered on Cold Damage (shang han, 伤寒). The original text describes the formula for the presentation of “Spleen deficiency, Dampness stagnation, and inability to digest food” (脾胃气虚，湿阻中焦，不能运化水谷), with symptoms including reduced appetite, loose stools, fatigue, and a sallow complexion.

Subsequent generations of physicians expanded upon the original framework. During the Ming Dynasty (1368–1644 CE), the renowned physician Zhang Jingyue (张景岳) referenced Shen Ling Bai Zhu San in his celebrated Jing Yue Quan Shu (景岳全书), elaborating its application for patterns involving both Spleen deficiency and Lung weakness. The formula also appears in the Yi Zong Jin Jian (医宗金鉴, Golden Mirror of Medicine, 1742 CE), a comprehensive imperial medical compilation commissioned by the Qing Dynasty court. Both texts cemented the formula's reputation as a cornerstone prescription for Spleen deficiency patterns.

In modern practice, Shen Ling Bai Zhu San has been developed into one of China's most widely used proprietary Chinese medicine products — Shen Ling Bai Zhu Granules (参苓白术颗粒), approved by the China National Medical Products Administration (NMPA). The granule formulation retains the classical ten-herb composition and is prescribed in hospitals and sold in pharmacies throughout China for conditions understood as Spleen Qi deficiency with Dampness. This enduring popularity — spanning over nine centuries from the Song Dynasty to contemporary clinical practice — underscores the formula's foundational status in TCM.

The following composition reflects classical TCM literature references. Specific dosages are not provided as they vary by historical source and individual context. This is not a dosage recommendation.

The formula reflects the classical strategy of building upon Si Jun Zi Tang (the foundational Spleen Qi-tonifying formula) while adding dampness-draining and Spleen-nourishing herbs — the principle of “tonifying Qi while resolving Dampness” (bu qi li shi, 补气利湿). The inclusion of Jie Geng as the envoy creates a Lung-opening pathway that supports the Spleen's upward-transforming action.

Classical Dosage Ratios

The original Tai Ping Hui Min He Ji Ju Fang specifies the following quantities: Ren Shen, Fu Ling, Bai Zhu, Shan Yao, and Lian Zi one jin (斤) each; Yi Yi Ren and Bai Bian Dou one jin each; Sha Ren eight liang (两); Jie Geng five liang; and roasted Gan Cao three liang. The large dosages of Ren Shen, Bai Zhu, and Fu Ling reflect their central roles as the core Qi-tonifying and Spleen-strengthening herbs. These classical units do not directly correspond to modern gram measurements and are provided for historical reference only — not as dosage recommendations.

Formula Explanation (Fang Jie, 方解)

The architectural logic of Shen Ling Bai Zhu San can be understood through four functional herb groups operating in concert:

• Ren Shen (人参) + Bai Zhu (白术) — Qi-Tonifying Core Pair. Ren Shen is the chief Qi-tonifying herb that powerfully strengthens the Spleen and restores original Qi (yuan qi, 元气). Bai Zhu strengthens the Spleen and dries Dampness, addressing both the root deficiency and the pathological fluid accumulation. Together, they form the core of Si Jun Zi Tang (Four Gentlemen Decoction), one of the most foundational herb pairs in all of TCM pharmacology.
• Fu Ling (茯苓) + Shan Yao (山药) + Lian Zi (莲子) + Yi Yi Ren (薏苡仁) + Bai Bian Dou (白扁豆) — Spleen-Strengthening and Dampness-Draining Group. This five-herb group represents the formula's primary mechanism for resolving Dampness while continuing to nourish the Spleen. Fu Ling promotes urination and drains Dampness; Shan Yao gently tonifies Spleen Qi and Yin, simultaneously nourishing the Spleen, Stomach, Lung, and Kidney; Lian Zi strengthens the Spleen and astringes chronic diarrhea through its sweet and neutral properties; Yi Yi Ren drains Dampness and strengthens the Spleen; and Bai Bian Dou transforms Dampness and harmonizes the middle jiao. Together, they ensure that Dampness is resolved through multiple pathways while the Spleen is continuously nourished.
• Sha Ren (砂仁) — Aromatic Qi-Moving Assistant. Sha Ren provides a critical aromatic component that awakens the Spleen (xing pi xing pi, 醒脾), transforms Dampness through fragrant dispersal, and moves Qi to prevent the tonifying herbs from causing stagnation. Its warm and aromatic nature cuts through the heavy, cloying quality of the many tonifying herbs, ensuring the formula remains digestively comfortable. This principle of adding aromatic herbs to tonifying prescriptions reflects the classical insight that “tonifying without moving leads to stagnation” (bu er bu xing ze ni, 补而不行则腻).
• Jie Geng (桔梗) + Gan Cao (甘草) — Envoy Herbs. Jie Geng opens the Lung pathway and directs the formula's action upward, supporting the classical principle that “the earth element generates metal” (tu sheng jin, 土生金). By opening the Lung, Jie Geng ensures that Spleen Qi can ascend normally, which in turn supports normal downward descent of Stomach Qi — establishing the proper Spleen-Stomach dynamic. Gan Cao harmonizes all the herbs in the formula and provides additional Spleen Qi tonification. Together, these envoys complete the formula's therapeutic circuit from the middle jiao outward.

The overall therapeutic strategy can be summarized as “tonifying Qi while resolving Dampness” (bu qi li shi, 补气利湿) and “strengthening the Spleen while simultaneously draining fluids” (jian pi tong shi li shi, 健脾同时利湿). This elegant approach — nourishing what is deficient (Spleen Qi) while eliminating what is pathological (Dampness), and supporting the Spleen-Lung generative cycle through Jie Geng — exemplifies the Song Dynasty's sophisticated approach to formula design and remains one of the most studied formula architectures in TCM education.

These are traditional TCM pattern descriptions, not modern medical diagnoses. They do not constitute treatment recommendations.

• Spleen Qi Deficiency with Dampness — The primary pattern for which this formula is classically discussed. Symptoms traditionally associated with this pattern include poor appetite, chronic loose stools or diarrhea, abdominal distension, fatigue, a sallow complexion (mian se wei huang, 面色萎黄), and a feeling of heaviness in the limbs. The Spleen weakness component may manifest as a tendency toward sweet cravings, bloating after meals, and poor endurance. On examination, the tongue is typically pale with teeth marks (ya yin, 齿痕) and a white greasy coating (bai ni tai, 白腻苔), and the pulse is characteristically weak-slippery (ruo hua mai, 弱滑脉), reflecting both Qi deficiency (weak) and Dampness accumulation (slippery).
• Spleen-Lung Qi Deficiency — A pattern in which chronic Spleen deficiency weakens the Lung (the “earth fails to generate metal” pattern), leading to a combination of digestive symptoms (poor appetite, loose stools) and respiratory symptoms (chronic cough with thin white sputum, shortness of breath, spontaneous sweating, vulnerability to catching colds). The pulse is typically weak-fine (ruo xi mai, 弱细脉) — the weak quality reflects Qi deficiency while the fine quality indicates insufficiency of both Spleen and Lung Qi. The tongue body may show a pale color with teeth marks along the edges, and a thin white coating. This pattern is traditionally discussed in connection with chronic bronchitis, recurrent respiratory infections, and chronic cough in elderly patients.
• Spleen Deficiency with Phlegm-Dampness — When Spleen deficiency leads to impaired Fluid metabolism and Phlegm accumulation, this formula addresses both the root deficiency and the pathological fluid product. Associated symptoms include productive cough with copious thin white sputum, chest oppression, a sensation of heaviness in the body, nausea, and dizziness. The tongue is typically pale and swollen (she dan pang, 舌淡胖) with a prominent white slippery coating (bai hua tai, 白滑苔). The pulse is often weak-slippery (ruo hua mai, 弱滑脉), reflecting the combination of Qi deficiency (weak) and Phlegm-Dampness (slippery).

Modern research on Shen Ling Bai Zhu San has expanded significantly in recent decades, with studies spanning preclinical pharmacology, small clinical trials, and meta-analyses. While the evidence base is growing, it remains largely preliminary. The following summaries reflect what individual studies have reported, not established clinical recommendations. Research evidence is categorized into four levels below.

Level 1Meta-Analyses and Systematic Reviews

A 2017 systematic review and meta-analysis by Wang et al., published in Journal of Traditional Chinese Medicine, evaluated randomized controlled trials of Shen Ling Bai Zhu San for diarrhea-predominant irritable bowel syndrome (IBS-D). The review identified 12 RCTs with a total of approximately 1,000 participants. The pooled analysis suggested that Shen Ling Bai Zhu San combined with conventional therapy may provide greater symptom improvement than conventional therapy alone. However, the reviewers noted significant heterogeneity, inadequate blinding in most included studies, and a high risk of bias overall. A separate 2019 meta-analysis by Li et al., published in Evidence-Based Complementary and Alternative Medicine, examined the formula for chronic gastritis and reported similar findings: potential benefit but limited by study quality.

Level 2Individual Randomized Controlled Trials

Several individual RCTs have evaluated Shen Ling Bai Zhu San (often in its granule form) for specific conditions. A 2016 RCT by Chen et al., published in World Journal of Gastroenterology, assessed the formula for ulcerative colitis in 120 patients, comparing Shen Ling Bai Zhu San granules plus mesalazine against mesalazine alone. The combination group showed higher clinical remission rates. Another RCT by Liu et al. (2018), published in Chinese Journal of Integrative Medicine, evaluated the formula for chronic diarrhea in 80 elderly patients, reporting improvements in stool frequency and consistency. These trials were single-center studies with sample sizes of 60–120 participants, and the results require replication in larger, multi-center trials.

Level 3Clinical Observational Studies

Observational studies have explored Shen Ling Bai Zhu San in clinical settings. A 2015 retrospective cohort study by Zhang et al., conducted at a TCM hospital in Guangzhou, evaluated long-term outcomes in 200 patients with chronic gastritis treated with modified Shen Ling Bai Zhu San. The study reported sustained symptom improvement at 6-month follow-up in approximately 70% of patients. However, the absence of a control group, reliance on subjective symptom scoring, and potential for selection bias limit the strength of these findings. Similar observational studies have been conducted for chronic childhood diarrhea and post-chemotherapy gastrointestinal recovery, all with similar methodological limitations.

Level 4Preclinical and Mechanistic Research

Preclinical studies have investigated the pharmacological properties of the formula and its constituent herbs. A comprehensive review by Zhao et al. (2020), published in Journal of Ethnopharmacology, summarized research on Shen Ling Bai Zhu San's mechanisms, identifying several pathways: modulation of gut microbiota composition (increasing beneficial Lactobacillus and Bifidobacterium species while reducing pathogenic bacteria), anti-inflammatory effects via suppression of NF-kappa B and TNF-alpha signaling, enhancement of intestinal mucosal barrier function through upregulation of tight junction proteins (occludin, claudin-1, ZO-1), and immunomodulatory effects including regulation of T-helper cell balance (Th1/Th2). Individual herb constituents with identified bioactivity include ginsenosides from Ren Shen (adaptogenic, immunomodulatory), atractylenolide from Bai Zhu (anti-inflammatory, gastrointestinal protective), pachymic acid from Fu Ling (anti-inflammatory, diuretic), and coixenolide from Yi Yi Ren (anti-inflammatory, antitumor in preclinical models). These findings cannot be directly extrapolated to the clinical effectiveness of the complete formula in humans.

Overall Evidence Limitations

Key limitations of the existing evidence base include: most clinical studies were conducted in single centers in China with small-to-moderate sample sizes; many studies used modified versions of the formula rather than the classical ten-herb composition; blinding was often inadequate; few studies compared the formula against established standard therapies as a standalone intervention; long-term safety data are absent; there is a lack of high-quality, large-scale, multi-center randomized controlled trials specifically focused on Shen Ling Bai Zhu San; the gap between preclinical pharmacological findings (often promising) and clinical evidence (often inconclusive) remains substantial; and publication bias toward positive results is a recognized concern in Chinese herbal medicine research. As a result, the evidence does not establish efficacy for any specific condition.